Hormone Replacement Therapy: Questions to Prepare for Your Medical Consultation

HRT replaces hormones (primarily estrogen, and often progesterone) that decline during perimenopause and menopause. It is a medical treatment aimed at managing symptoms and, in some cases, supporting longer-term health outcomes. It is not a cosmetic intervention, a lifestyle supplement, or a guaranteed solution. Understanding this distinction matters before your appointment, because it shapes the questions you ask and the expectations you bring.

It is also worth separating the concept of symptom relief from broader well-being. Some people experience significant improvement in quality of life with HRT; others find symptoms manageable without it, or prefer alternative approaches. Neither choice reflects a failure. The NHS menopause symptoms page describes a wide range of symptoms associated with perimenopause and menopause, from hot flushes and sleep disruption to mood changes and cognitive effects. Recognizing which of these you are experiencing and how much they affect your daily functioning is useful preparation before you speak to a clinician.

HRT is a treatment decision, not a screening test. A clinician cannot diagnose menopause from a single hormone blood test alone in most cases; the assessment involves your age, symptom history, and clinical picture together.

One of the most practical things you can do before your consultation is to document your symptoms in specific terms. Vague descriptions like “not feeling right” are harder for a clinician to work with than a clear account of what you experience, how often, and how it affects your sleep, work, relationships, or daily activities.

Consider keeping a brief symptom diary for two to four weeks before your appointment. Note the frequency and severity of hot flushes, any changes to your menstrual pattern if relevant, sleep quality, mood fluctuations, vaginal discomfort, and any cognitive changes such as difficulty concentrating. This is not about self-diagnosing. It is about giving your clinician accurate raw material.

Also think about timing. When did symptoms begin? Have they changed over time? Are there patterns, worse at certain times of the month, or linked to stress or sleep? These details help distinguish perimenopausal symptoms from other possible causes, which your clinician will want to consider. Arriving with this information means less time reconstructing your history and more time discussing options.

Your clinician will ask about your medical history, but you should also come prepared to ask how your history affects your suitability for HRT. Certain conditions (including some types of hormone-sensitive cancer, blood clotting disorders, and liver disease) may affect which forms of HRT are appropriate or whether it is recommended at all. You do not need to know the answers in advance, but you should be ready to discuss your history honestly and to ask directly how it shapes your options.

Useful questions to consider raising include: Does my personal or family medical history change which type of HRT might be appropriate for me? Are there conditions I have that would make one route of administration preferable over another? If I have had previous gynecological surgery, how does that affect my options? These are not alarming questions. They are the kind of individual risk assessment that good clinical practice involves. NICE guidance on menopause identification and management supports individualized assessment rather than a one-size approach.

HRT is not a single product. It comes in different hormone combinations, different doses, and different routes of administration, including patches, gels, sprays, tablets, and vaginal preparations. The route matters because it affects how hormones are absorbed and, in some cases, the associated risk profile. Transdermal preparations, for example, are absorbed through the skin and have a different absorption pathway than oral tablets.

Before your appointment, it helps to understand that you may be offered choices rather than a single prescription. Questions worth preparing include: What are the differences between the forms available to me? Are there reasons you would recommend one route over another for my situation? If I have a uterus, what type of progesterone would be included and why does that matter? Understanding the rationale behind a recommendation, not just the recommendation itself, helps you engage meaningfully with the decision rather than simply accepting or refusing it.

This is often the area people find most confusing, partly because media coverage of HRT has historically swung between enthusiasm and alarm. A measured consultation will acknowledge that HRT carries both potential benefits and potential risks, and that these vary by individual, type of HRT, duration of use, and age at which treatment begins.

Rather than asking “is HRT safe?” — which invites an oversimplified answer — consider asking: What are the specific benefits most relevant to my symptom pattern? What risks are associated with the type you are recommending, and how do they compare to my baseline risk? How does duration of use affect the risk picture? These questions invite a more nuanced response. Be cautious about interpreting relative risk figures without context; a clinician can help you understand whether a stated increase in risk is meaningful given your individual starting point. Uncertainty is a legitimate part of this conversation, not a sign that your clinician is being evasive.

Starting HRT is not a one-time decision. It involves an initial trial period, assessment of whether symptoms improve, and periodic review of whether continuing is appropriate. Before leaving your appointment, you should have a clear picture of what happens next, not just a prescription.

Useful questions include: How long before I might notice a difference? What should I do if I experience side effects? When will we review whether this is working? Are there symptoms that should prompt me to contact you sooner? A follow-up plan is a normal part of HRT management, not a sign that something is expected to go wrong. NICE guidance supports ongoing review as part of good practice. If you are not offered a follow-up arrangement, it is reasonable to ask when and how you should make contact to reassess.

HRT is one option among several for managing menopausal symptoms, and your consultation is an appropriate place to ask about alternatives, whether because HRT is not suitable for you, or because you want to understand the full picture before deciding. Non-hormonal prescription options exist for some symptoms, and lifestyle factors such as sleep hygiene, physical activity, and dietary patterns are often discussed alongside or instead of medication.

Ask your clinician: If HRT is not appropriate for me, what alternatives are there for my specific symptoms? Are there lifestyle approaches that evidence supports for the symptoms I am experiencing? If I want to try HRT but am uncertain, is a time-limited trial a reasonable approach? Framing alternatives as part of an informed choice, rather than as a fallback, helps you leave the appointment with a broader sense of your options. Meaningful well-being and function are achievable through different routes, and your clinician should be able to discuss this without implying that one path is inherently superior.

Beyond clinical questions, there are practical matters worth thinking through in advance. If you take other medications, bring a list, some interact with hormonal treatments. If you have had relevant investigations recently, such as blood pressure checks or smear tests, knowing the results or bringing documentation can save time. If you feel anxious about the appointment, it is entirely reasonable to bring a trusted person with you, or to write your questions down so you do not forget them under pressure.

Consider also what you want from the appointment in terms of outcome. Are you looking for a prescription, a second opinion, more information before deciding, or reassurance that your symptoms are being taken seriously? Being clear about your goal, even just to yourself, helps you assess whether the consultation has been useful. If you leave feeling unheard or unclear, you have the option to seek a further appointment or ask for clarification in writing.

Changes in sleep, concentration, nutrition, movement, and recovery may be relevant to a broader SENSES health assessment. Bring your questions and any existing clinical information so that the review can consider your circumstances and current care.

These guides provide education about women’s health and menopause. They do not establish that specialist menopause consultations, hormone testing, or prescribing are included in a SENSES program. Confirm the appropriate professionals and any external referrals through the individual suitability discussion.

Identify the symptoms the treatment is intended to address, the expected review point and the circumstances that require earlier contact. Ask how the recommendation relates to your medical history and why the particular option was selected. The NICE menopause guideline provides a framework for an individual discussion, not a universal prescription.

Keep an accurate record of any medicine changes and the responsible prescriber. Medicines-reconciliation guidance is particularly relevant when several clinicians or countries are involved in care.

Ask what to do if symptoms remain troublesome or side effects occur. Do not adjust the regimen independently to match an online account. The menopause and sleep guide and sexual and urinary symptoms guide help you describe which concerns remain, so follow-up addresses the actual experience rather than only a general treatment label.

Read women’s health guides, reviewing medicines and the SENSES midlife focus.

• NICE NG23: Menopause identification and management
• NHS: Menopause and perimenopause symptoms
• NICE NG5: Medicines optimisation and medicines reconciliation
• NICE NG197: Shared decision making
• NICE guidance on menopause identification and management

General educational information. Individual assessment and treatment decisions belong with an appropriately qualified clinician.